Synthesis of CdTe quantum dot-conjugated CC49 and their application for in vitro imaging of gastric adenocarcinoma cells

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-9

  Zhang, Yun Peng ^a   Sun, Peng ^a   Zhang, Xu Rui ^a   Yang, Wu Li ^a   Si, Cheng Shuai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Nanotechnology; Quantum dots; Stomach neoplasms

Indexed keywords

CADMIUM TELLURIDE; CELL CULTURE; CELLS; FLUORESCENCE IMAGING; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; II-VI SEMICONDUCTORS; INFRARED DEVICES; MONOCLONAL ANTIBODIES; NANOCRYSTALS; NANOTECHNOLOGY; OPTICAL PROPERTIES; PROBES; SPECTRUM ANALYSIS; TUMORS;

ADENOCARCINOMA CELLS; EMISSION WAVELENGTH; FLUORESCENCE SPECTRUM ANALYSIS; GASTRIC EPITHELIAL CELLS; NEAR-INFRARED QUANTUM DOTS; NEGATIVE CONTROL; STOMACH NEOPLASMS; TUMOR-ASSOCIATED GLYCOPROTEIN-72;

SEMICONDUCTOR QUANTUM DOTS;

EID: 84881226810     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-294     Document Type: Article

References (35)

1. Gómez-Martin C, Sánchez A, Irigoyen A, Llorente B, Pérez B, Serrano R, Safont MJ, Falcó E, Lacasta A, Reboredo M, Aparicio J, Dueñas R, Muñoz ML, Regueiro P, Sanchez-Viñes E, López RL: Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen. Clin Transl Oncol 2012, 14(9):689-697.
2. Pericleous P, Gazouli M, Lyberopoulou A, Rizos S, Nikiteas N, Efstathopoulos EP: Quantum dots hold promise for early cancer imaging and detection. Int J Cancer 2012, 131:519-528.
3. Chen C, Peng J, Sun SR, Peng CW, Li Y, Pang DW: Tapping the potential of quantum dots for personalized oncology: current status and future perspectives. Nanomedicine (Lond) 2012, 7(3):411-428.
4. Xue B, Deng DW, Cao J, Liu F, Li X, Akers W, Achilefu S, Gu YQ: Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging. Dalton Trans 2012, 41(16):4935-4947.
5. Yang K, Cao YA, Shi C, Li ZG, Zhang FJ, Yang J, Zhao C: Quantum dotbased visual in vivo imaging for oral squamous cell carcinoma in mice. Oral Oncol 2010, 46(12):864-868.
6. Frangioni JV, Kim SW, Ohnishi S, Kim S, Bawendi MG: Sentinel lymph node mapping with type-II quantum dots. Methods Mol Biol 2007, 374:147-159.
7. van Vlerken LE, Amiji MM: Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006, 3(2):205-216.
8. Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JA, Waggoner AS, Bruchez MP: Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug Chem 2007, 18(2):389-396.
9. Gaponik N, Talapin DV, Rogach AL, Hoppe K, Shevchenko EV, Kornowski A, Eychmuller A, Weller H: Thiol-capping of CdTe nanocrystals: an alternative to organometallic synthetic routes. J Phys Chem B 2002, 106:7177-7185.
10. Derfus AM, Chan WCW, Bhatia SN: Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
11. Gao X, Cui Y, Levenson RM, Chung LW, Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
12. Voura EB, Jaiswal JK, Mattoussi H, Simon SM: Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 2004, 10:993-998.
13. Kim SW, Kim S, Tracy JB, Jasanoff A, Bawendi MG: Phosphine oxide polymer for water-soluble nanoparticles. J AmChemSoc 2005, 127:4556-4557.
14. Soltesz EG, Kim S, Laurence RG, DeGrand AM, Parungo CP, Dor DM, Cohn LH, Bawendi MG, Frangioni JV, Mihaljevic T: Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg 2005, 79:269-277.
15. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV: Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22:93-97.
16. Li P, Sun P, Yang W, Zhang X: Real-time mapping of rat stomach lymph nodes by quantum dots. Scand J Gastroenterol 2012, 47:454-460.
17. Chen L, Wang Y, Liu X, Dou S, Liu G, Hnatowich DJ, Rusckowski M: A new TAG-72 cancer marker peptide identified by phage display. Cancer Lett 2008, 272(1):122-132.
18. Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D: Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986, 46(2):850-857.
19. Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P, Schlom J: Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res 1988, 48(16):4588-4596.
20. Sheer DG, Schlom J, Cooper HL: Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res 1988, 48(23):6811-6818.
21. Guo J, Yang W, Wang C: Systematic study of the photoluminescence dependence of thiol-capped CdTe nanocrystals on the reaction conditions. J Phys Chem B 2005, 109(37):17467-17473.
22. Demasa JN, Crosby GA: The measurement of photoluminescence quantum yields. J Phys Chem 1971, 75(8):991-1024.
23. Hu M, Yan J, He Y, Lu H, Weng L, Song S, Fan C, Wang L: Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dot-based microfluidic protein chip. ACS Nano 2010, 4(1):488-494.
24. Wittel UA, Jain M, Goel A, Baranowska-Kortylewicz J, Kurizaki T, Chauhan SC, Agrawal DK, Colcher D, Batra SK: Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49. Biochem Biophys Res Commun 2005, 329(1):168-176.
25. Tian J, Liu R, Zhao Y, Peng Y, Hong X, Xu Q, Zhao S: Synthesis of CdTe/CdS/ZnS quantum dots and their application in imaging of hepatocellular carcinoma cells and immunoassay for alpha fetoprotein. Nanotechnology 2010, 21(30):305101.
26. Yang K, Zhang FJ, Tang H, Zhao C, Cao YA, Lv XQ, Chen D, Li YD: In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice. Int J Nanomedicine 2011, 6:1739-1745.
27. Yokota T, Ishiyama S, Saito T, Teshima S, Shimotsuma M, Yamauchi H: Treatment strategy of limited surgery in the treatment guidelines for gastric cancer in Japan. Lancet Oncol 2003, 4(7):423-428.
28. Allum WH, Griffin SM, Watson A, Colin-Jones D, on behalf of the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology, and the British Association of Surgical Oncology: Guidelines for the management of oesophageal and gastric cancer. Gut 2002, 50(Suppl 5):v1-v23.
29. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J: Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986, 46(6):3118-3124.
30. Stramignoni D, Bowen R, Atkinson BF, Schlom J: Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1982, 31(5):543-552.
31. Nuti M, Teramoto YA, Mariani-Costantini R, Hand PH, Colcher D, Schlom J: A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer 1982, 29(5):539-545.
32. Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J: Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 1983, 43(2):736-742.
33. Seldom J, Greiner J, Horan Hand P, Colcher D, Inghirami G, Weeks M, Pestka S, Fisher PB, Noguchi P, Kufe D: Monoclonal antibodies to breast cancerassociated antigens as potential reagents in the management of breast cancer. Cancer (Phila) 1984, 54(11 Suppl):2777-2794.
34. Keenan AM, Colcher D, Larson SM, Schlom J: Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodinated monoclonal antibody B72.3. J Nucl Med 1984, 25(11):1197-1203.
35. Coleher D, Keenan AM, Larson SM, Schlom J: Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res 1984, 44(12 Pt 1):5744-5751.